{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:33:00Z","timestamp":1773300780844,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.cyto.2014.05.022","type":"journal-article","created":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T21:30:58Z","timestamp":1402522258000},"page":"131-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Fractalkine levels are elevated early after PCI-treated ST-elevation myocardial infarction; no influence of autologous bone marrow derived stem cell injection"],"prefix":"10.1016","volume":"69","author":[{"given":"Ida Unhammer","family":"Njerve","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svein","family":"Solheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ketil","family":"Lunde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Arnesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingebj\u00f8rg","family":"Seljeflot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2014.05.022_b0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/01.ATV.0000095360.62479.1F","article-title":"Fractalkine in vascular biology: from basic research to clinical disease","volume":"24","author":"Umehara","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cyto.2014.05.022_b0010","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/385640a0","article-title":"A new class of membrane-bound chemokine with a CX3C motif","volume":"385","author":"Bazan","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2014.05.022_b0015","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1182\/blood-2008-07-170787","article-title":"CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival","volume":"113","author":"Landsman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2014.05.022_b0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.yjmcc.2008.05.009","article-title":"Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure","volume":"45","author":"Husberg","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cyto.2014.05.022_b0025","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1160\/TH12-03-0195","article-title":"Fractalkine is an independent predictor of mortality in patients with advanced heart failure","volume":"108","author":"Richter","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cyto.2014.05.022_b0030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/cvr\/cvr221","article-title":"Detrimental effect of fractalkine on myocardial ischaemia and heart failure","volume":"92","author":"Xuan","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cyto.2014.05.022_b0035","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/cvr\/cvp341","article-title":"Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling","volume":"85","author":"White","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cyto.2014.05.022_b0040","first-page":"CD006536","article-title":"Stem cell treatment for acute myocardial infarction","volume":"2","author":"Clifford","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cyto.2014.05.022_b0045","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/eurheartj\/ehn456","article-title":"Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction","volume":"29","author":"Korf-Klingebiel","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cyto.2014.05.022_b0050","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/00365510701884584","article-title":"Inflammatory responses after percutaneous coronary intervention in patients with acute myocardial infarction or stable angina pectoris","volume":"68","author":"Solheim","year":"2008","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.cyto.2014.05.022_b0055","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa055706","article-title":"Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction","volume":"355","author":"Lunde","year":"2006","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cyto.2014.05.022_b0060","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.cyto.2014.05.022_b0065","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jacc.2007.10.032","article-title":"Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months\u2019 follow-up","volume":"51","author":"Lunde","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cyto.2014.05.022_b0070","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1161\/01.ATV.0000190672.36490.7b","article-title":"Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy","volume":"25","author":"Damas","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cyto.2014.05.022_b0075","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1475-2840-10-50","article-title":"Changes of dendritic cells and fractalkine in type 2 diabetic patients with unstable angina pectoris: a preliminary report","volume":"10","author":"Yao","year":"2011","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cyto.2014.05.022_b0080","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1253\/circj.CJ-11-1457","article-title":"Independent roles of monocyte chemoattractant protein-1, regulated on activation, normal T-cell expressed and secreted and fractalkine in the vulnerability of coronary atherosclerotic plaques","volume":"76","author":"Li","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.cyto.2014.05.022_b0085","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1253\/circj.CJ-09-0484","article-title":"Upregulation of fractalkine and its receptor, CX3CR1, is associated with coronary plaque rupture in patients with unstable angina pectoris","volume":"74","author":"Ikejima","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.cyto.2014.05.022_b0090","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1054-8807(02)00111-4","article-title":"Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease","volume":"11","author":"Wong","year":"2002","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.cyto.2014.05.022_b0095","doi-asserted-by":"crossref","first-page":"37993","DOI":"10.1074\/jbc.M106434200","article-title":"Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1)","volume":"276","author":"Garton","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2014.05.022_b0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2362.2007.01912.x","article-title":"The expression of TNF-alpha converting enzyme at the site of ruptured plaques in patients with acute myocardial infarction","volume":"38","author":"Satoh","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cyto.2014.05.022_b0105","first-page":"479","article-title":"Molecular mapping of the regenerative niche in a murine model of myocardial infarction","volume":"29","author":"Alves","year":"2012","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.cyto.2014.05.022_b0110","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1089\/scd.2008.0023","article-title":"Human cord blood mononuclear cells decrease cytokines and inflammatory cells in acute myocardial infarction","volume":"17","author":"Henning","year":"2008","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.cyto.2014.05.022_b0115","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1089\/met.2012.0052","article-title":"Fractalkine and its receptor (CX3CR1) in patients with stable coronary artery disease and diabetes mellitus","volume":"10","author":"Njerve","year":"2012","journal-title":"Metab Synd Relat Disord"},{"key":"10.1016\/j.cyto.2014.05.022_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2007.10.005","article-title":"Inflammatory responses after intracoronary injection of autologous mononuclear bone marrow cells in patients with acute myocardial infarction","volume":"155","author":"Solheim","year":"2008","journal-title":"Am Heart J"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614001550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614001550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T20:43:23Z","timestamp":1649364203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466614001550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1043466614001550"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2014.05.022","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fractalkine levels are elevated early after PCI-treated ST-elevation myocardial infarction; no influence of autologous bone marrow derived stem cell injection","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2014.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}